Literature DB >> 25779474

Advances in stroke prevention.

Ayesha Z Sherzai1, Mitchell S V Elkind.   

Abstract

Stroke remains to be a leading cause of disability. However, optimal strategies can prevent up to 80% of strokes. A large body of evidence supports many strategies for primary and secondary prevention of stroke. The purpose of this paper is to highlight recent major advances for management of modifiable medical and behavioral risk factors of stroke. Specific studies are highlighted, including those related to atrial fibrillation (AF), hypertension, revascularization, hyperlipidemia, antiplatelets, smoking, diet, and physical activity. Effective strategies include the use of novel oral anticoagulants for AF, antiplatelet therapy, and intensive lowering of atherosclerosis risk factors.
© 2015 New York Academy of Sciences.

Entities:  

Keywords:  epidemiology; prevention; risk factors; stroke

Mesh:

Year:  2015        PMID: 25779474      PMCID: PMC7008637          DOI: 10.1111/nyas.12723

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN: 0077-8923            Impact factor:   5.691


  92 in total

1.  Mediterranean-style diet and risk of ischemic stroke, myocardial infarction, and vascular death: the Northern Manhattan Study.

Authors:  Hannah Gardener; Clinton B Wright; Yian Gu; Ryan T Demmer; Bernadette Boden-Albala; Mitchell S V Elkind; Ralph L Sacco; Nikolaos Scarmeas
Journal:  Am J Clin Nutr       Date:  2011-11-09       Impact factor: 7.045

2.  US trends in prevalence, awareness, treatment, and control of hypertension, 1988-2008.

Authors:  Brent M Egan; Yumin Zhao; R Neal Axon
Journal:  JAMA       Date:  2010-05-26       Impact factor: 56.272

3.  Clopidogrel with aspirin in acute minor stroke or transient ischemic attack.

Authors:  Yongjun Wang; Yilong Wang; Xingquan Zhao; Liping Liu; David Wang; Chunxue Wang; Chen Wang; Hao Li; Xia Meng; Liying Cui; Jianping Jia; Qiang Dong; Anding Xu; Jinsheng Zeng; Yansheng Li; Zhimin Wang; Haiqin Xia; S Claiborne Johnston
Journal:  N Engl J Med       Date:  2013-06-26       Impact factor: 91.245

4.  Antihypertensive treatment and secondary prevention of cardiovascular disease events among persons without hypertension: a meta-analysis.

Authors:  Angela M Thompson; Tian Hu; Carrie L Eshelbrenner; Kristi Reynolds; Jiang He; Lydia A Bazzano
Journal:  JAMA       Date:  2011-03-02       Impact factor: 56.272

5.  Selecting patients with atrial fibrillation for anticoagulation: stroke risk stratification in patients taking aspirin.

Authors:  Brian F Gage; Carl van Walraven; Lesly Pearce; Robert G Hart; Peter J Koudstaal; B S P Boode; Palle Petersen
Journal:  Circulation       Date:  2004-10-11       Impact factor: 29.690

6.  B-type natriuretic peptide and C-reactive protein in the prediction of atrial fibrillation risk: the CHARGE-AF Consortium of community-based cohort studies.

Authors:  Moritz F Sinner; Katherine A Stepas; Carlee B Moser; Bouwe P Krijthe; Thor Aspelund; Nona Sotoodehnia; João D Fontes; A Cecile J W Janssens; Richard A Kronmal; Jared W Magnani; Jacqueline C Witteman; Alanna M Chamberlain; Steven A Lubitz; Renate B Schnabel; Ramachandran S Vasan; Thomas J Wang; Sunil K Agarwal; David D McManus; Oscar H Franco; Xiaoyan Yin; Martin G Larson; Gregory L Burke; Lenore J Launer; Albert Hofman; Daniel Levy; John S Gottdiener; Stefan Kääb; David Couper; Tamara B Harris; Brad C Astor; Christie M Ballantyne; Ron C Hoogeveen; Andrew E Arai; Elsayed Z Soliman; Patrick T Ellinor; Bruno H C Stricker; Vilmundur Gudnason; Susan R Heckbert; Michael J Pencina; Emelia J Benjamin; Alvaro Alonso
Journal:  Europace       Date:  2014-07-18       Impact factor: 5.214

7.  High-sensitivity C-reactive protein predicts mortality but not stroke: the Northern Manhattan Study.

Authors:  M S V Elkind; J M Luna; Y P Moon; K M Liu; S L Spitalnik; M C Paik; R L Sacco
Journal:  Neurology       Date:  2009-10-20       Impact factor: 9.910

8.  Atorvastatin reduces the risk of cardiovascular events in patients with carotid atherosclerosis: a secondary analysis of the Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) trial.

Authors:  Henrik Sillesen; Pierre Amarenco; Michael G Hennerici; Alfred Callahan; Larry B Goldstein; Justin Zivin; Michael Messig; K Michael Welch
Journal:  Stroke       Date:  2008-10-09       Impact factor: 7.914

9.  Baseline smoking status and the long-term risk of death or nonfatal vascular event in people with stroke: a 10-year survival analysis.

Authors:  Joosup Kim; Seana L Gall; Helen M Dewey; Richard A L Macdonell; Jonathan W Sturm; Amanda G Thrift
Journal:  Stroke       Date:  2012-10-25       Impact factor: 7.914

10.  Secondary prevention in non-rheumatic atrial fibrillation after transient ischaemic attack or minor stroke. EAFT (European Atrial Fibrillation Trial) Study Group.

Authors: 
Journal:  Lancet       Date:  1993-11-20       Impact factor: 79.321

View more
  11 in total

Review 1.  Brain health and shared risk factors for dementia and stroke.

Authors:  Hannah Gardener; Clinton B Wright; Tatjana Rundek; Ralph L Sacco
Journal:  Nat Rev Neurol       Date:  2015-10-20       Impact factor: 42.937

2.  Factors associated with young adults' knowledge regarding family history of Stroke.

Authors:  Maria Jose Melo Ramos Lima; Thereza Maria Magalhães Moreira; Raquel Sampaio Florêncio; Predro Braga
Journal:  Rev Lat Am Enfermagem       Date:  2016-11-21

3.  Clinical features and biological markers of lung cancer-associated stroke.

Authors:  Xingrui Xie; Li Chen; Jinsheng Zeng; Chao Qin; Daobin Cheng; Xinxian Wei; Zhijian Liang
Journal:  J Int Med Res       Date:  2016-11-10       Impact factor: 1.671

4.  The effects of a single session of chiropractic care on strength, cortical drive, and spinal excitability in stroke patients.

Authors:  Kelly Holt; Imran Khan Niazi; Rasmus Wiberg Nedergaard; Jens Duehr; Imran Amjad; Muhammad Shafique; Muhammad Nabeel Anwar; Harrison Ndetan; Kemal S Turker; Heidi Haavik
Journal:  Sci Rep       Date:  2019-02-25       Impact factor: 4.379

5.  Monocyte/lymphocyte ratio is associated with carotid stenosis in ischemic stroke: A retrospective analysis.

Authors:  Bo Zuo; Sha Zhu; Xue Meng; Danhua Zhao; Jun Zhang
Journal:  Brain Behav       Date:  2019-09-30       Impact factor: 2.708

6.  Evaluating the effects of socioeconomic status on stroke and bleeding risk scores and clinical events in patients on oral anticoagulant for new onset atrial fibrillation.

Authors:  Kourosh Ravvaz; John A Weissert; Arshad Jahangir; Christian T Ruff
Journal:  PLoS One       Date:  2021-03-18       Impact factor: 3.240

7.  Na+/K+‑ATPase DR region‑specific antibody protects U251 cells against hypoxia reperfusion‑induced injury via the PI3K/AKT and ERK pathways.

Authors:  Huilin Gong; Pengbiao Lü; Jiangwei Zhang; Dandong Li; Jin Zheng; Jinning Song
Journal:  Mol Med Rep       Date:  2017-09-26       Impact factor: 2.952

8.  The Effect of Hedysarum multijugum Maxim.-Chuanxiong rhizoma Compound on Ischemic Stroke: A Research Based on Network and Experimental Pharmacology.

Authors:  Kailin Yang; Liuting Zeng; Anqi Ge; Yongmei Shi; Xiaofei Zhu; Wenlong Liu; Jinwen Ge
Journal:  Oxid Med Cell Longev       Date:  2020-10-06       Impact factor: 6.543

9.  Modulation of stroke risk in chronic kidney disease.

Authors:  Julia Arnold; Don Sims; Charles J Ferro
Journal:  Clin Kidney J       Date:  2015-12-23

10.  Perceptions of recurrence risk and behavioural changes among first-ever and recurrent stroke survivors: A qualitative analysis.

Authors:  Beilei Lin; Zhenxiang Zhang; Yunfei Guo; Wenna Wang; Yongxia Mei; Shanshan Wang; Yao Tong; Nazia Shuaib; Daphne Cheung
Journal:  Health Expect       Date:  2021-08-06       Impact factor: 3.377

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.